These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23414465)

  • 1. Urological medical oncology: land of opportunity.
    Jones R
    Future Oncol; 2013 Feb; 9(2):149-52. PubMed ID: 23414465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interview with Johann de Bono for Future Oncology. Interviewed by Francesca Lake.
    de Bono J
    Future Oncol; 2012 Nov; 8(11):1381-2. PubMed ID: 23148611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pazopanib for the treatment of renal cancer.
    Al-Marrawi MY; Rini B
    Expert Opin Pharmacother; 2011 May; 12(7):1171-89. PubMed ID: 21470066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olaparib recommendations for ovarian cancer patients.
    Johnson P; Westcott G
    Future Oncol; 2016 Jan; 12(2):149-51. PubMed ID: 26616222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nursing considerations with pazopanib therapy: focus on metastatic renal cell carcinoma.
    Bourdeanu L; Twardowski P; Pal SK
    Clin J Oncol Nurs; 2011 Oct; 15(5):513-7. PubMed ID: 21951737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trials and tribulations of cytotoxic and targeted breast cancer therapy: a clinical perspective on the next phase of progress. Interview by Sophia Maprayil and Alexandra Hemsley.
    Twelves C
    Expert Rev Anticancer Ther; 2013 Mar; 13(3):251-5. PubMed ID: 23477510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pazopanib for the treatment of metastatic renal cell carcinoma.
    Pick AM; Nystrom KK
    Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of pazopanib in the treatment of renal cell carcinoma.
    Zivi A; Cerbone L; Recine F; Sternberg CN
    Expert Opin Drug Saf; 2012 Sep; 11(5):851-9. PubMed ID: 22861374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
    Tobisu K
    Jpn J Clin Oncol; 2012 May; 42(5):363-7. PubMed ID: 22450928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma.
    Sonpavde G; Hutson TE; Sternberg CN
    Expert Opin Investig Drugs; 2008 Feb; 17(2):253-61. PubMed ID: 18230058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pazopanib: therapeutic developments.
    Limvorasak S; Posadas EM
    Expert Opin Pharmacother; 2009 Dec; 10(18):3091-102. PubMed ID: 19954277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pazopanib: Clinical development of a potent anti-angiogenic drug.
    Schutz FA; Choueiri TK; Sternberg CN
    Crit Rev Oncol Hematol; 2011 Mar; 77(3):163-71. PubMed ID: 20456972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic treatment in metastatic urothelial cancer.
    Galsky MD
    Lancet Oncol; 2012 Aug; 13(8):748-9. PubMed ID: 22819171
    [No Abstract]   [Full Text] [Related]  

  • 14. Pazopanib. Kidney cancer: many risks, but is there a benefit for patients?
    Prescrire Int; 2011 Mar; 20(114):64-6. PubMed ID: 21648224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy in urology: what can we do now and where are we heading?
    Bozzini G; Colin P; Betrouni N; Nevoux P; Ouzzane A; Puech P; Villers A; Mordon S
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):261-73. PubMed ID: 22959806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Active studies of the Working Association for Urological Oncology (AUO) in 2006].
    Rexer H
    Urologe A; 2006 Feb; 45(2):229-40. PubMed ID: 16440204
    [No Abstract]   [Full Text] [Related]  

  • 17. Pazopanib in renal cell carcinoma.
    Ward JE; Stadler WM
    Clin Cancer Res; 2010 Dec; 16(24):5923-7. PubMed ID: 21059813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes and challenges: a career in prostate surgery.
    Kirby R
    Future Oncol; 2013 Sep; 9(9):1267-9. PubMed ID: 23980673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pazopanib, a new therapy for metastatic soft tissue sarcoma.
    Verweij J; Sleijfer S
    Expert Opin Pharmacother; 2013 May; 14(7):929-35. PubMed ID: 23488774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nursing considerations for patients receiving pazopanib for renal cell carcinoma.
    Becze E
    ONS Connect; 2012 Feb; 27(2):16-7. PubMed ID: 22375508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.